ClinConnect ClinConnect Logo
Search / Trial NCT00001295

Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

Launched by NATIONAL CANCER INSTITUTE (NCI) · Nov 3, 1999

Trial Information

Current as of May 10, 2025

Completed

Keywords

Follow Up Treatment

ClinConnect Summary

Background:

It may be in the interest of the CCR to continue to follow and treat certain subjects after they have completed their treatment and participation on a research protocol.

Objective:

To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for another active research protocol.

Eligibility:

Subjects who have been previously enrolled on and received treatment according to an approved CCR research protocol. (clinical trial)

It is in the best...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Subjects of any age who have been previously enrolled and treated on an approved CCR research treatment protocol.
  • It is in the best interests of the subject and the CCR for the subject to continue to receive treatment and follow-up at the NIH.
  • The subject or guardian signs the informed consent and agrees to the proposed treatment regimen.
  • EXCLUSION CRITERIA:
  • Subjects who have not been previously treated on a CCR research treatment protocol.
  • Subjects who are receiving an investigational therapy.

About National Cancer Institute (Nci)

The National Cancer Institute (NCI) is a prominent component of the National Institutes of Health (NIH), dedicated to advancing cancer research and improving patient outcomes through innovative clinical trials. As a leading sponsor of cancer-related studies, NCI focuses on facilitating the development of new therapies, enhancing prevention strategies, and understanding the biology of cancer. The institute collaborates with academic institutions, healthcare providers, and industry partners to conduct rigorous clinical trials that aim to translate scientific discoveries into effective treatments. NCI’s commitment to fostering a robust research environment supports the mission to eliminate cancer as a major health problem.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Caryn Steakley, R.N.

Principal Investigator

National Cancer Institute (NCI)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials